Company / Free Cash Flow
MEDICINOVA INC Free Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$9.8M
FY2025
5-year range
-$12.9M / -$7.5M
FY2021-FY2025
Trend
-31.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$13M to -$10M over the past 2 years.
Based on SEC 10-K filings.
-$10M in FY2025.
Improved from -$13M to -$10M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 31.7% year-over-year.
- Peak free cash flow was recorded in FY2014.
- Lowest free cash flow in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.8M | -31.7% |
| FY2024 | -$7.5M | +42.3% |
| FY2023 | -$12.9M | +0.0% |
| FY2022 | -$12.9M | -37.3% |
| FY2021 | -$9.4M | -1257.5% |
| FY2014 | $813.0K | +106.8% |
| FY2013 | -$11.9M | +10.3% |
| FY2012 | -$13.3M | +0.0% |
| FY2011 | -$13.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026